Cash & equivalents increased 53.4%
Cash & equivalents changed +53.4% from the comparable as-filed period. The change ranks at the 74th percentile of 217 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +53.4% from the comparable as-filed period. The change ranks at the 74th percentile of 217 prior comparable changes.
Inventory changed +35.5% from the comparable as-filed period. The change ranks at the 70th percentile of 50 prior comparable changes.
Net income changed +348.2% from the comparable as-filed period. The change ranks at the 99th percentile of 167 prior comparable changes.
Operating income changed +1528.7% from the comparable as-filed period. The change ranks at the 98th percentile of 133 prior comparable changes.
Operating margin changed +2002 basis points from the comparable as-filed period. The change ranks at the 21th percentile of 61 prior comparable changes.
Research & development changed +27.7% from the comparable as-filed period. The change ranks at the 65th percentile of 133 prior comparable changes.
Revenue changed +66.9% from the comparable as-filed period. The change ranks at the 48th percentile of 61 prior comparable changes.
Stock-based compensation changed -22.4% from the comparable as-filed period. The change ranks at the 37th percentile of 97 prior comparable changes.
Selling, general & administrative changed +7.6% from the comparable as-filed period. The change ranks at the 17th percentile of 59 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.